Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

SAVA

Cassava Sciences

NASDAQ

14.92

+2.17

+17.02%

After Hours: 14.85 -0.07 -0.47% 19:01 07/26 EDT

OPEN

12.94

PREV CLOSE

12.75

HIGH

14.94

LOW

12.86

VOLUME

3.66M

TURNOVER

52 WEEK HIGH

32.10

52 WEEK LOW

8.79

MARKET CAP

715.80M

P/E (TTM)

-12.7543

Cassava Sciences: Turning The Corner Into A Brick Wall

Seeking Alpha · 2d ago

Here's How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today

Cassava Sciences has outperformed the market over the past 5 years by 43.6% on an annualized basis. The company has an average annual return of 56.63%. If an investor bought $1000 of SAVA stock 5 years ago, it would be worth $9,083.94 today.

Benzinga · 3d ago

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, Mattel, Tellurian

The S&P 500 and the Nasdaq recouped some of the previous week's losses on Monday. The Dow Jones Industrial Average was up 0.22% in early trading. Walt Disney, Mattel and Tellurian are among the stocks on the move.

Reuters · 4d ago

Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials

Cassava Sciences Inc is in the final stages of testing its Alzheimer's drug candidate, simufilam. The company is conducting Phase 3 trials to demonstrate the drug's efficacy and safety. Rick Barry, the executive chairman of Cassava Sciences, wrote a letter to shareholders and employees.

Benzinga · 4d ago

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD) fell sharply during Monday’s mid-day session. CrowdStrike shares dipped over 11% on Friday after the company suffered a major outage impacting businesses around the world. MIRA Pharmaceuticals,. Inc. Shares climbed 148% to $1.98. Selective Insurance Group shares dipped 13.2%.

Benzinga · 4d ago

Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?

MIRA Pharmaceuticals (NASDAQ:MIRA) stock is up 318.1% on Monday. The company released data from its pre-clinical study of Ketamir-2. The drug is being studied as a potential treatment for neurological and neuropsychiatric disorders. MIRA stock could benefit if the company is able to move forward with its IND plans. Nio, Reddit and Cassava Sciences are also moving today. We have all of the hottest stock market news investors need to know.

Investorplace · 4d ago

SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update

Cassava Sciences (NASDAQ:SAVA) stock is up 29% on Monday after the company provided an update for its Alzheimer’s disease treatment. SAVA stock is experiencing heavy trading on Monday with more than 7.6 million shares on the move. The company is expecting to release data from its first Phase 3 clinical trial by December 2024. There are also stories about Nvidia, Starbucks and CrowdStrike in the stock market on Monday.

Investorplace · 4d ago

BUZZ-U.S. STOCKS ON THE MOVE-Verizon Communications, Reddit, Starbucks

Wall Street rose on Monday. The Dow Jones Industrial Average was unchanged and the S&P 500 was up 0.52%. Verizon Communications, Reddit and Starbucks were among the biggest losers. The major U.S. Stock markets rose after a week of declines. Gold prices fell as gold miners fell.

Reuters · 4d ago

About SAVA

Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of Alzheimer's disease dementia in Phase 3 clinical studies. The Company has two biopharmaceutical assets under development. Its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer's disease dementia. Its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer's disease from a small sample of blood. Simufilam targets an altered form of a protein called filamin A in the Alzheimer's brain. It owns rights to its drug and diagnostic assets and related technologies, without royalty obligations to any third party.

Webull offers Cassava Sciences Inc stock information, including NASDAQ: SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAVA stock methods without spending real money on the virtual paper trading platform.